The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex.

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Pre-B cell development involves alternating proliferation and differentiation phases.
• Understanding the molecular regulators of these phases is crucial for controlling cell fate and preventing diseases like leukemia.

Purpose of the Study:

• To investigate the roles of protein arginine methyl transferase 1 (PRMT1) and B cell translocation gene 2 (BTG2) in pre-B cell differentiation.
• To elucidate the molecular mechanism by which PRMT1 and BTG2 regulate cell cycle progression and immunoglobulin gene rearrangement.

Main Methods:

• Utilized in vitro and in vivo models of pre-B cell development.
• Investigated the interaction and function of PRMT1 and BTG2.
• Analyzed cell cycle progression, gene expression (Rag1, Rag2), and protein methylation (CDK4).

Main Results:

• The BTG2-PRMT1 module was identified as critical for pre-B cell differentiation.
• This module induced cell-cycle arrest, re-expression of Rag1/Rag2, and immunoglobulin light chain gene rearrangements.
• PRMT1 methylated cyclin-dependent kinase 4 (CDK4), preventing CDK4-Cyclin-D3 complex formation and cell cycle progression.
• BTG2 and PRMT1 inhibited proliferation of BCR-ABL1-transformed pre-B cells in vitro and in vivo.

Conclusions:

• The BTG2-PRMT1 module is a key regulator of pre-B cell differentiation.
• This module acts by inhibiting CDK4 activity, thereby controlling cell cycle progression.
• The findings reveal a novel mechanism for inhibiting pre-B cell leukemogenesis.